Yoshiyuki Yukawa, Shinya Ohashi, Yusuke Amanuma, Yukie Nakai, Mihoko Tsurumaki, Osamu Kikuchi, Shin’ichi Miyamoto, Tsunehiro Oyama, Toshihiro Kawamoto, Tsutomu Chiba, Tomonari Matsuda, Manabu Muto.

Impairment of aldehyde dehydrogenase 2 increases accumulation of acetaldehyde-derived DNA damage in the esophagus after ethanol ingestion.

Am J Cancer Res. 2014 May 26;4(3):279-84. eCollection 2014.

Kagawa S, Natsuizaka M, Whelan KA, Facompre N, Naganuma S, Ohashi S, Kinugasa H, Egloff AM, Basu D, Gimotty PA, Klein-Szanto AJ, Bass AJ, Wong KK, Diehl JA, Rustgi AK, Nakagawa H.

Cellular senescence checkpoint function determines differential Notch1-dependent oncogenic and tumor-suppressor activities

Oncogene 34：2347-2359：2014.

Kanai M

Therapeutic application of curcumin for patients with pancreatic cancer

World Journal of Gastroenterology 20(28):9384-9391:2014

Watanabe N, Narimatsu H, Noh JY, Kunii Y, Mukasa K, Matsumoto M, Suzuki M, Sekiya K, Ohye H, Yoshihara A, Iwaku K, Kobayashi S, Kameyama K, Kobayashi K, Nishikawa Y, Kami M, Sugino K, Ito K

Rituximab-including combined modality treatment for primary thyroid lymphoma: an effective regimen for elderly patients

Thyroid. 24(6):994-999:2014.

Yamada A, Minamiguchi S, Sakai Y, Horimatsu T, Muto M, Chiba T, Boland CR, Goel A

Colorectal advanced neoplasms occur through dual carcinogenesis pathways in individuals with coexisting serrated polyps

PLoS One　9(5):e98059：2014

Peng Xue, Masashi Kanai, Yukiko Mori, Takafumi Nishimura, Norimitsu Uza, Yuzo Kodama, Yoshiya Kawaguchi, Kyoichi Takaori, Shigemi Matsumoto, Shinji Uemoto, Tsutomu Chiba.

Comparative outcomes between initially unresectable and recurrent cases of advanced pancreatic cancer following palliative chemotherapy

Pancreas 2014; 43(3):411-6

Funakoshi T, Yasui H, Boku N, Fukutomi A, Yamazaki K, Machida N, Todaka A, Tsushima T, Hamauchi S, Yokota T, Onozawa Y, Komatsu H, Endo M

Clinicopathological features and outcomes of gastric cancer patients with pulmonary lymphangitis carcinomatosa

Jpn J Clin Oncol. 44(9):792-798:2014.

Ikezawa K, Kanai M, Ajiki T, Tsukamoto T, Toyokawa H, Terajima H, Furuyama H, Nagano H, Ikai I, Kuroda N, Awane M, Ochiai T, Takemura S, Miyamoto A, Kume M, Ogawa M, Takeda Y, Taira K, Ioka T.

Patients with recurrent biliary tract cancer have a better prognosis than those with unresectable disease: retrospective analysis of a multi-institutional experience with patients of advanced biliary tract cancer who received palliative chemotherapy

J Hepatobiliary Pancreat Sci 21(2):98-104:2014

Kou T, Kanai M, Ikezawa K, Ajiki T, Tsukamoto T, Toyokawa H, Yazumi S, Terajima H, Furuyama H, Nagano H, Ikai I, Kuroda N, Awane M, Ochiai T, Takemura S, Miyamoto A, Kume M, Ogawa M, Takeda Y, Taira T, Ioka T

Comparative Outcomes of Elderly and Non-elderly Patients Receiving First-Line Palliative Chemotherapy for Advanced Biliary Tract Cancer

J Gastroenterol Hepatol 29:403-408:2014

Yamanaka K, Hatano E, Kanai M, Tanaka S, Yamamoto K, Narita M, Nagata H, Ishii T, Machimoto T, Taura K, Uemoto S.

A single-center analysis of the survival benefits of adjuvant gemcitabine chemotherapy for biliary tract cancer

J Clin Oncol 19(3):185-9, 2014.